Ken Griffin Gh Research PLC Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Gh Research PLC stock. As of the latest transaction made, Citadel Advisors LLC holds 2,800 shares of GHRS stock, worth $19,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,800
Previous 3,200
12.5%
Holding current value
$19,852
Previous $37,000
51.35%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GHRS
# of Institutions
32Shares Held
27.8MCall Options Held
2.8KPut Options Held
3.8K-
Bvf Inc San Francisco, CA10.4MShares$73.7 Million2.21% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.69MShares$47.4 Million0.62% of portfolio
-
Lynx1 Capital Management LP San Juan, PR4.2MShares$29.7 Million10.05% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$23.6 Million0.35% of portfolio
-
Verition Fund Management LLC Greenwich, CT1.06MShares$7.5 Million0.04% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $369M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...